Posts tagged All News
Dishman Pharmaceuticals and Chemicals Limited – Annual General Meeting Updates (18-09-2015)
Dishman Pharmaceuticals and Chemicals Limited has submitted to the Exchange a copy of Minutes of Extra Ordinary General Meeting of the Company held on August 14, 2015.......
Granules India up 6.6% on USFDA nod for painkiller drug (18-09-2015)
The US FDA has approved Granules' abbreviated new drug application for Ibuprofen tablets USP, 400 mg, 600 mg and 800 mg on September 16.
Sensex, Nifty remain strong (18-09-2015)
The India VIX (Volatility) index is down 16.80% at 18.30. The BSE Mid-cap Index is trading up 1.40% at 10,701, whereas BSE Small-cap Index is trading up 1.21% at 10,815.
Nifty call: Make use of dips to buy contract (18-09-2015)
Nifty September Futures (8,041)
The Nifty futures contract started on a positive note with a gap-up at 7,965 levels and then reclaimed the 8,000-mark as the Fed held rates steady. <...
Sensex, Nifty flex muscle as Fed keeps rate firm; FMCG weak (18-09-2015)
Axis Bank, ICICI Bank, MM, HDFC Bank and SBI are top gainers while Tata Motors, HUL, GAIL, Bharti Airtel and ITC are losers.
Rurban mission to help penetrate rural mkt:Bajaj Electrical (18-09-2015)
In an interview with CNBC-TV18, Shekhar Bajaj, CMD - Bajaj Electrical said the 'Rurban' mission of the government will be catalyst for rural markets growth.
Nifty hovers around 8,050; rupee dips below 66/$ (18-09-2015)
At 13:00 pm, the Sensex was higher by 433 points at 26,396 and the Nifty gained 132 points at 8,032
P. I. Industries Ltd. – A Unique Business Model can make it a Great Play on Agri & CSM Space (18-09-2015)
sir as most of its csm business comes from japan, recent downgrade will affect going forward?
Jubilant Life Sciences receives ANDA approval for Zolmitriptan ODT Tablets (18-09-2015)
As on June 30, 2015, Jubilant Life Sciences had a total of 815 filings for formulations of which 389 have been approved in various regions globally.
Jubilant Life Sciences receives ANDA approval for Zolmitriptan ODT Tablets (18-09-2015)
As on June 30, 2015, Jubilant Life Sciences had a total of 815 filings for formulations of which 389 have been approved in various regions globally.